Molecular Biology Laboratory, Pediatrics National Institute, Mexico.
Cleft Palate Craniofac J. 2021 Sep;58(9):1128-1134. doi: 10.1177/1055665620980238. Epub 2020 Dec 17.
To screen for interferon regulatory factor 6 (IRF6) pathogenic variants in patients clinically diagnosed with nonsyndromic cleft lip palate (NSCL/P) and establish the proportion of misdiagnosed Van der Woude syndrome (VWS) cases, which could have biased previous NSCL/P case-control association studies.
Retrospective case series.
Tertiary care children's hospital.
One hundred seventy-two unrelated Mexican patients with NSCL/P, 128 of whom had previously been included in a NSCL/P case-control association study.
Sanger sequencing of the 9 exons were performed, all variants respect with sequence reference were reported and classified for their pathogenic significance according to the American College of Medical Genetics and Genomics guidelines.
Seven percent of cases were familial. No pathogenic variant was identified in . We identified 12 previously reported benign variants; their frequencies did not significantly differ from those reported for individuals of Mexican ancestry. Three of them were uncommon intronic variants not reported in ClinVar. The rs2235371 and rs2235375 variants, which were previously analyzed in a NSCL/P case-control association study (containing 132 patients, 128 of whom were analyzed herein) did not show discordant association results comparing to the 370 controls from the previous study.
The misdiagnosis of -related VWS as NSCL/P appears to be infrequent in our sample, suggesting that mutational screening of would have a low diagnostic yield in patients with NSCL/P. The absence of pathogenic alleles could be related to the application of an exhaustive clinical evaluation that discarded the syndromic forms and/or the low proportion of familial cases included.
在临床上诊断为非综合征性唇腭裂(NSCL/P)的患者中筛选干扰素调节因子 6(IRF6)致病变体,并确定误诊的 Van der Woude 综合征(VWS)病例的比例,这可能会对先前的 NSCL/P 病例对照关联研究产生偏差。
回顾性病例系列。
三级儿童保健医院。
172 名无亲缘关系的墨西哥 NSCL/P 患者,其中 128 名先前已纳入 NSCL/P 病例对照关联研究。
对 9 个外显子进行 Sanger 测序,报告所有与序列参考相符的变体,并根据美国医学遗传学与基因组学学院的指南对其致病性进行分类。
7%的病例为家族性。未发现致病性变体。我们鉴定出 12 种先前报道的良性变体;它们的频率与墨西哥裔个体报道的频率没有显著差异。其中 3 种是罕见的内含子变体,未在 ClinVar 中报道。先前在 NSCL/P 病例对照关联研究中分析的 rs2235371 和 rs2235375 变体(包含 132 例患者,其中 128 例在此处进行了分析)与先前研究的 370 例对照相比,并未显示出不一致的关联结果。
在我们的样本中,与相关的 VWS 误诊为 NSCL/P 似乎不常见,这表明在 NSCL/P 患者中,对 的突变筛查可能诊断率较低。缺乏 致病等位基因可能与应用详尽的临床评估有关,该评估排除了综合征形式和/或纳入的家族性病例比例较低。